Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 10 May 2024 06:41:19 +0200Mon, 15 Apr 2024 13:54:00 +0200Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 30, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jakaviHuman medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 30, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jakaviMon, 15 Apr 2024 13:54:00 +0200Human medicineJakavi-H-C-PSUSA-00010015-201602 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)https://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500217353_en.pdfJakavi-H-C-PSUSA-00010015-201602 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)https://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500217353_en.pdfTue, 29 Nov 2016 01:00:00 +0100Human medicine